Draft rilpivirine film-coated tablets 25 mg product-specific 4 bioequivalence guidance

  • Email
  • Help

Document details

Download document Draft rilpivirine film-coated tablets 25 mg product-specific 4 bioequivalence guidance
Reference number EMA/CHMP/356878/2017
Status draft: consultation open
First published 2017-07-28
Last updated 2017-07-28
Consultation start date 2017-07-28
Consultation end date 2017-10-31
Email address for submissions pkwp@ema.europa.eu

Summary

This document provides product-specific guidance on the demonstration of the rilpivirine.